Oregon Psilocybin: Market Failure or Strategic Attrition?

Is the Oregon Psilocybin program actually failing, or are we just witnessing the "messy middle" of a brand-new profession? If you’ve heard headlines about service center closures or market oversaturation, this episode offers a necessary reality check.

Entheogen Institute director Coeli Dwivedi, MS, LPF, breaks down the current state of Oregon Psilocybin Services through the lens of public health and the "Diffusion of Innovation" framework. We explore why current shifts aren't signs of a "collapse," but are actually predictable milestones in the maturation of a regulated health system.

⚖️ SYSTEMS INSIGHTS:

✨ The Innovation Curve: Why moving from the "Innovator" phase to "Early Adoption" always looks like a crisis from the outside.

✨ Strategic Attrition: Understanding why early participants exit as expectations clarify and the field professionalizes.

✨ Market Realities: A data-driven look at why there is still significant room for new facilitators despite the "oversaturation" narrative.

🔗 CONNECT WITH ENTHEOGEN INSTITUTE:📩 Newsletter: https://mailchi.mp/bc97570b9ae9/subscribe-to-our-mailing-list 🌐 Website: https://entheotraining.com🎓 Apply for Training: https://entheotraining.com/apply-now-1📸 Instagram: @entheogeninstitute

⚠️ EDUCATIONAL CONTENT DISCLAIMER:This episode discusses peer-reviewed research and legally regulated psilocybin programs in Oregon and Colorado. This information is for educational purposes only and should not be considered medical advice. Always consult with a licensed facilitator or health care provider.

Brain Scans & Psilocybin: The 2024 Nature Study Breakdown

How does the brain actually change during and after a psilocybin session? Entheogen Institute director Coeli Dwivedi, MS, LPF, breaks down a groundbreaking multimodal fMRI study that tracked brain changes from baseline through 3 weeks post-session.

We explore what the data reveals about neuroplasticity, brain network reconfiguration, and why the integration period is a critical biological window for healing.

🔬 STUDY HIGHLIGHTS (Nature, 2024):✨ Network Desynchronization: A 2.6-fold increase in brain network activity during the acute experience.✨ The "Plasticity Window": Measurable changes in the Default Mode Network (DMN) and hippocampus lasting up to 3 weeks.✨ Subjective Experience: How individual brain changes directly predicted the intensity of the mystical experience.

🕒 CHAPTERS:0:00 Introduction1:21 The Research Design: Nature Journal Study 20243:56 Key Findings4:38 Impact of Mystical Meaningful Experience5:25 Clinical Implications for Facilitators6:33 Closing Thoughts & Participant Shout-out

🧠 CLINICAL TAKEAWAY:The 3-week post-session window is a period of heightened neuroplasticity where new neural pathways are forming. Understanding how to support this process is the difference between a "trip" and a life-changing therapeutic outcome.

📚 STUDY REFERENCE:Doss et al. (2024). "Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder." Nature.

🔗 CONNECT WITH ENTHEOGEN INSTITUTE:📩 Newsletter: https://mailchi.mp/bc97570b9ae9/subscribe🌐 Website: https://entheotraining.com🎓 Apply for Training: https://entheotraining.com/apply-now-1📸 Instagram: @entheogeninstitute

⚠️ EDUCATIONAL CONTENT DISCLAIMER:This video discusses peer-reviewed research and legally regulated psilocybin programs in Oregon and Colorado. This information is for educational purposes only and should not be considered medical advice. Always consult with a licensed facilitator or health care provider.

What is Psilocybin? Neuroscience, History, and the 5-HT2A Receptor

What is psilocybin, and why is it currently at the center of a global conversation regarding mental health and consciousness?

In this video, Coeli Dwivedi, founder of the Entheogen Institute, breaks down the fundamentals of this naturally occurring compound. We move beyond the "magic mushroom" labels to look at the biological reality of psilocybin, its interaction with serotonin receptors, and its deep-rooted history across global cultures.

🍄 KEY TOPICS COVERED:

🧠 Neuroscience: How psilocybin interacts with the brain’s serotonin (5-HT2A) receptors.🌍 Global History: The ancient roots of mushroom use across the world.🔬 Modern Science: The convergence of clinical research and indigenous wisdom.⚖️ Regulation: The birth of the licensed facilitator role in Oregon and Colorado.

🕒 CHAPTERS:0:00 Introduction: What is Psilocybin0:35 Context: Psilocybin Assisted Therapy (PAT)1:00 Basic Pharmacology and Impact2:04 Psilocybin for Depression: Long-Term Data2:35 Mushrooms Belong to the World3:16 Ancient Wisdom meets Modern Science4:02 The Birth of the Licensed Facilitator4:23 Next Steps: Feeling the Call5:12 Final Thoughts & How to Follow

🔗 CONNECT WITH ENTHEOGEN INSTITUTE:📩 Newsletter: https://mailchi.mp/bc97570b9ae9/subscribe🌐 Website: https://entheotraining.com🎓 Apply for Training: https://entheotraining.com/apply-now-1📸 Instagram: @entheogeninstitute

⚠️ EDUCATIONAL CONTENT DISCLAIMER:This video discusses peer-reviewed research and legally regulated psilocybin programs in Oregon and Colorado. This information is for educational purposes only and should not be considered medical advice. Always consult with a licensed facilitator or health care provider.

The Hope Paradox: 5-Year Outcomes for Psilocybin & Depression

Hope is easy to sell, but long-term outcomes are much harder to sustain. In this video, we review the newly published five-year follow-up study (Gukasyan et al., 2024) examining the effects of psilocybin-assisted therapy for people diagnosed with Major Depressive Disorder (MDD).

We bridge the gap between "selling hope" and "modern facilitation" by looking at how to move clients from the initial breakthrough into a fully supported daily practice.

🔬 WHAT WE BREAK DOWN:✨ The 5-Year Study: Remission and response rates years after the initial treatment.✨ Protocol vs. Reality: Comparing the original Johns Hopkins trial results to long-term durability.✨ The Integration Gap: How neuroplastic coaching and facilitator support turn "hope" into proven impact.✨ Clinical Insights: New perspectives on SSRI interactions and MDD recovery.

🕒 CHAPTERS:0:00 The Hope Paradox: Why Long-Term Outcomes Matter0:57 Study Breakdown: 5-Year Follow Up2:02 Protocol from Original Study3:17 Results of Original Study (1 Year)3:51 5-Year Follow Up Results5:33 Participant Feedback6:33 Integrated Facilitation Practice8:39 Closing the Loop: Turning Hope into Impact

📚 STUDY REFERENCED:Gukasyan et al., 2024. Five-Year Outcomes of Psilocybin-Assisted Therapy for Major Depressive Disorder. Journal of Psychedelic Studies.

🔗 CONNECT WITH ENTHEOGEN INSTITUTE:📩 Newsletter: https://mailchi.mp/bc97570b9ae9/subscribe🌐 Website: https://entheotraining.com🎓 Apply for Training: https://entheotraining.com/apply-now-1📸 Instagram: @entheogeninstitute

⚠️ EDUCATIONAL CONTENT DISCLAIMER:This video discusses peer-reviewed research and legally regulated psilocybin programs in Oregon and Colorado. This information is for educational purposes only and should not be considered medical advice. Always consult with a licensed facilitator or health care provider regarding your specific needs.

Psilocybin for Cluster Headaches: The Yale "Pulse Protocol" Breakdown

Cluster headaches are often described as one of the most painful conditions known to medicine—frequently rated as more severe than childbirth or kidney stones. For those living with these "suicide headaches," traditional treatments often fall short.

In this video, Coeli Dwivedi breaks down a breakthrough 2024 study from the Yale School of Medicine. The research reveals a specific "pulse" protocol that resulted in a staggering 47% reduction in headache frequency.

🧠 KEY STUDY INSIGHTS:✨ The Pulse Protocol: Understanding the exact 3-dose regimen (Day 0, 5, and 10) and why timing matters more than intensity.✨ The Results: Breaking down the 0.97 effect size and the massive reduction in "abortive" medication use.✨ Neurological Context: How psilocybin interacts with neural systems involved in pain regulation and rhythmic patterning.

🕒 CHAPTERS:0:00 Introduction to Cluster Headaches1:01 Yale School of Medicine Study Review2:35 The Pulse Protocol: Timing & Dosage3:13 Breaking Down the Results3:59 Key Findings & Data4:46 Limitations of the Study5:30 Clinical Implications for Facilitators6:47 Final Thoughts

📚 STUDY REFERENCED:Schindler, E. A. D., et al. (2024). "Psilocybin pulse regimen reduces cluster headache attack frequency..." Journal of the Neurological Sciences.

🔗 CONNECT WITH ENTHEOGEN INSTITUTE:📩 Newsletter: https://mailchi.mp/bc97570b9ae9/subscribe🌐 Website: https://entheotraining.com🎓 Apply for Training: https://entheotraining.com/apply-now-1📸 Instagram: @entheogeninstitute

⚠️ EDUCATIONAL CONTENT DISCLAIMER:This video discusses peer-reviewed research and legally regulated psilocybin programs in Oregon and Colorado. This information is for educational purposes only and should not be considered medical advice. Always consult with a licensed facilitator or health care provider.

Psilocybin for Healthcare Burnout: The 2024 JAMA Study Breakdown

If you're a healthcare worker experiencing burnout, this December 2024 study shows what's possible. A single psilocybin session in a therapeutic setting helped frontline clinicians recover from depression, with benefits lasting at least six months.

I'm Coeli, founder of Entheogen Institute. As a licensed facilitator, I’m seeing firsthand how this work is moving from "experimental" to a grounded, professional reality in Oregon and Colorado.

📊 STUDY HIGHLIGHTS (JAMA Network Open):✨ The Participants: 30 frontline clinicians with COVID-related depression and burnout.✨ The Results: Depression scores dropped 21 points (psilocybin) vs. 9 points (placebo).✨ Sustained Relief: Benefits remained significant at the 6-month follow-up.

🕒 TIMESTAMPS:0:00 Introduction to Burnout in Healthcare Workers1:00 Methodology and Results: The JAMA Clinical Trial3:14 Real-World Applications and Participant Feedback4:42 Global Expansion and the Future of the Field4:57 The Importance of Set and Setting5:51 Training and Accessibility for Healthcare Workers7:53 Conclusion and Final Thoughts

🌲 REAL-WORLD ACCESS:Oregon has completed 15,000+ licensed sessions since 2022. Colorado is launching now, and New Mexico is close behind. This is a rapidly growing field with a massive need for trained, ethical facilitators.

📚 FULL CITATION:Back AL, et al. (2024). Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care. JAMA Network Open.

🔗 CONNECT WITH ENTHEOGEN INSTITUTE:📩 Newsletter: https://mailchi.mp/bc97570b9ae9/subscribe🌐 Website: https://entheotraining.com🎓 Apply for Training: https://entheotraining.com/apply-now-1📸 Instagram: @entheogeninstitute

⚠️ EDUCATIONAL CONTENT DISCLAIMER:This video discusses peer-reviewed research and legally regulated psilocybin programs in Oregon and Colorado. This information is for educational purposes only and should not be considered medical advice. Always consult with a licensed facilitator or health care provider regarding your specific needs.

What Most Psilocybin Facilitator Programs Miss | The 3 Critical Gaps

If you're researching training programs, you’ve likely seen the same curriculum everywhere: History, Pharmacology, and Integration. While those are important, they aren't enough to sustain a professional practice.

In this video, licensed facilitator and Entheogen Institute founder Coeli Dwivedi, MS, LPF, breaks down the three critical areas most programs skip—and why these gaps lead to burnout, imposter syndrome, or re-traumatization.

✨ THE THREE PILLARS MOST PROGRAMS SKIP:1️⃣ Nervous System Regulation: The art of co-regulation as the foundation of safety.2️⃣ Ongoing Transformation: Creating structures for the work to live in you after training ends.3️⃣ Embodiment Practice: Moving beyond lectures into the "felt sense" of space-holding.

🕒 CHAPTERS:0:00 Introduction: The Critical Training Gap1:09 Why This Matters: Career Stoppers2:40 #1: Nervous System & Co-Regulation6:53 #2: Structures for Ongoing Transformation13:12 #3: Embodiment Practice15:24 Conclusion: Choosing the Right Program

🎓 ABOUT ENTHEOGEN INSTITUTE:After 10 licensed training cycles and nearly 100 facilitators trained in Oregon and Colorado, we’ve seen exactly what separates sustainable facilitators from those who struggle. Our curriculum is built for the real-world reality of licensed facilitation.

🔗 CONNECT WITH ENTHEOGEN INSTITUTE:📩 Newsletter: https://mailchi.mp/bc97570b9ae9/subscribe🌐 Website: https://entheotraining.com🎓 Apply for Training: https://entheotraining.com/apply-now-1📸 Instagram: @entheogeninstitute

⚠️ EDUCATIONAL CONTENT DISCLAIMER:This video discusses legal, state-licensed psilocybin facilitation training in Oregon and Colorado under Measure 109 and the Natural Medicine Health Act. This information is for educational purposes only and should not be considered medical advice.